by MM360 Staff | Jun 3, 2025 | Myeloma News
Source: Pharmacy Times articles Panelists discuss how key clinical and economic factors, such as efficacy, safety, cost-effectiveness, patient adherence, and proper monitoring, should be considered when evaluating new low-density lipoprotein cholesterol...
by MM360 Staff | Jun 3, 2025 | Uncategorized
Source: CureToday articles Zejula with Zytiga and prednisone delayed cancer growth and symptoms in patients with castration-sensitive prostate cancer and HRR gene mutations. Read More
by MM360 Staff | Jun 2, 2025 | Myeloma News
Source: Pharmacy Times articles The CDC has updated its COVID-19 vaccine guidance for children and pregnant individuals, sparking a debate among health experts and concerns over insurance coverage. Read More
by MM360 Staff | Jun 2, 2025 | Uncategorized
Source: ASCO Daily News Dr. John Sweetenham shares highlights from Day 4 of the 2025 ASCO Annual Meeting, including new research on maintenance therapy in small cell lung cancer and a virtual reality psychosocial intervention for patients undergoing hematopoietic stem...
by MM360 Staff | Jun 2, 2025 | Uncategorized
Source: CureToday articles Dr. Sarah Sammons discusses side effects associated with RLY-2608, and how it effects patients with HR-positive, HER2-negative advanced breast cancer. Read More
